Mesco Pharmaceuticals (Delisted) share price

BSE: 500274Pharmaceuticals & Biotechnology

Mesco Pharmaceuticals Ltd. · Face value ₹10 · Listed Mar 1994

Last traded ₹4.54 on 10 Jan 2022

Delisted on 12 Nov 2023.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

Share price history

Daily closes since Dec 2018, adjusted for splits and bonuses

Daily close, ₹ per share

Q3 results, quarter to Dec 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.00 Cr
Operating profit
₹0.00 Cr
Net profit
₹0.00 Cr
Earnings per share
₹0.00

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income0.0
  7. Finance costs0.0
  8. Profit before tax0.0
  9. Tax0.0
  10. Net profit0.0

Mesco Pharmaceuticals results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2021. Results for the quarter to Mar 2022 were due by 30 May 2022, 60 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
00.0Mar 190−0.1Jun 1900.0Sep 1900.0Dec 1900.0Mar 2000.0Jun 2000.0Sep 2000.0Dec 2000.0Mar 2100.0Jun 2100.0Sep 2100.0Dec 21
Peak revenue ₹0.00 Cr, quarter to Mar 2019A loss in 12 of the 12 quarters shown

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreMar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Q1Sep 2018Dec 2018Q3Filed 13 FebMar 2019Jun 2019Q1Sep 2019Dec 2019Q3Mar 2020Jun 2020Q1Sep 2020Dec 2020Q3Mar 2021Jun 2021Q1Sep 2021Dec 2021Q3
Revenue from operations–––––0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
–––––0.030.360.000.020.090.010.000.000.000.000.000.000.000.000.00
Materials and goods bought–––––0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Employee costs–––––0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Other expenses–––––0.030.360.000.020.090.010.000.000.000.000.000.000.000.000.00
Operating profit before depreciation–––––−0.03−0.360.00−0.02−0.09−0.010.000.000.000.000.000.000.000.000.00
Depreciation and amortisation–––––0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Other income–––––0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Finance costs–––––0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
One-off items–––––0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax−0.23−0.05−0.01−0.01−0.01−0.03−0.360.00−0.02−0.09−0.010.000.000.000.000.000.000.000.000.00
Tax0.00––––0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Net profit−0.24−0.05−0.01−0.01−0.01−0.03−0.360.00−0.02−0.09−0.010.000.000.000.000.000.000.000.000.00
Earnings per share−₹0.12−₹0.03−₹0.01––−₹0.01−₹0.18₹0.00−₹0.01−₹0.04−₹0.01−₹0.01₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00
Earnings per share in rupees, restated for later splits and bonuses.

5 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
−0.3Mar 17−0.1Mar 180−0.411,13,927Mar 190−0.111Mar 2000.011Mar 21
Peak revenue ₹0.00 Cr, year to Mar 2019A loss in 5 of the 5 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income0.0
  7. One-off items0.0
  8. Finance costs0.0
  9. Profit before tax0.0
  10. Tax0.0
  11. Net profit0.0

What the company owns

  • Plant, investments and other assets₹0 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹11 Cr
  • Owed to suppliers₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Dec 2021, the latest four quarters added.

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Dec 2021Twelve months
Revenue from operations––0.000.000.000.00
––0.410.100.000.00
Materials and goods bought––0.000.000.000.00
Employee costs––0.000.000.000.00
Other expenses––0.410.100.000.00
Operating profit before depreciation––−0.41−0.100.000.00
Depreciation and amortisation––0.000.000.000.00
Operating profit after depreciation––−0.41−0.100.000.00
Other income––0.000.000.000.00
Finance costs–0.000.000.000.000.00
One-off items––0.000.000.000.00
Profit before tax−0.26−0.09−0.41−0.100.000.00
Tax0.00–0.000.000.000.00
Net profit−0.26−0.09−0.41−0.100.000.00
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2017: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2018: the statement does not state its revenue or depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2021, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Mar 2020Mar 2021Sep 2021Half year
−10,91,490−11−11−11
Share capital19,73,810202020
Reserves−30,65,300−31−31−31
Borrowings11,13,927111111
2,360000
11,13,927111111
Total assets24,797000
20,838000
Assets turning to cash within a year3,959000
Net debt11,09,968111111
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2021, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Sep 2021Half year
0.000.00
0.000.00
Of which working capital–0.00
Capital spending0.000.00
Free cash flow0.000.00
Cash from investing−0.030.00
Cash from financing0.000.00
Dividends paid0.000.00
Shares bought back0.000.00
Shares issued0.000.00
Net change in cash−0.040.00
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Earnings per share−₹0.13–−₹0.20–₹0.00
Diluted earnings per share−₹0.13–−₹0.20–₹0.00
Earnings per share is left blank for the years to Mar 2018 and Mar 2020: the earnings per share stated has the opposite sign to the profit stated beside it, so it is not shown.

Ratios

Standalone, years to March.

RatioMar 2019Mar 2020Mar 2021
Return on capital employed0.0%−48.0%−2.4%
Asset turnover0.000.000.00
Assets per rupee of net worth−0.02−0.02−0.02
Sales per rupee of plant0.000.000.00
Plant being built, % of plant in use–0.0%0.0%
Debt to equity is left blank for the years to Mar 2019, Mar 2020 and Mar 2021: net worth is below zero, so there is no shareholders' money to set the borrowings against. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Return on assets, latest year
−2.0%
Measure3 years
Return on capital employed, average−16.8%
Asset turnover, average0.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2021.

₹ croreLatest year
Cash from operations0.00
Cash from investing−0.03
Cash from financing0.00
Capital spending0.00
Dividends paid0.00
Shares bought back0.00
Shares issued for cash0.00
Borrowings raised0.00
Borrowings repaid0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2021
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets17.14
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2021 the company reports one business segment, Pharmaceuticals, which carries all its revenue.

Mesco Pharmaceuticals share price by year

Each calendar year to 2022.

YearClose at year endChangeHighest closeLowest close
20224.54+4.8%4.544.54
20214.33−41.5%7.703.61
20207.40−33.9%10.647.40
201911.20+14.3%12.409.76
20189.80–10.509.01
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2018 is from its first session, 17 Dec 2018. The close is the year's last trade for 2022 (10 Jan 2022), 2021 (28 Oct 2021), 2020 (20 Oct 2020) and 2019 (13 Dec 2019).

Recent sessions

The 10 trading days to 10 Jan 2022, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
10 Jan 20224.544.544.544.544.54700
28 Oct 20214.334.334.334.334.33400
27 Oct 20214.554.554.554.554.55300
26 Oct 20214.704.704.704.704.70100
22 Oct 20214.744.744.744.744.74500
19 Oct 20214.654.654.654.654.65300
12 Oct 20214.654.654.654.654.65100
7 Oct 20214.894.894.894.894.89100
6 Oct 20215.145.145.145.145.14200
5 Oct 20215.415.415.415.415.41100
Prices in ₹ per share as traded, not adjusted.

Company details

BSE code
500274
ISIN
INE839X01015
Industry
Pharmaceuticals & Biotechnology
CIN
L24111UR1986PLC015895
Corporate identity number, the registrar of companies' code for it
Incorporated
1986
Registered office
Upper Kesalton, Tallital, Nainital 263001, Uttarakhand
Share registrar
Skyline Financial Services Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments